DEDICATED SUPPORT FOR YOUR TREATMENT EXPERIENCE

Serial Number 97740705
731

Registration Progress

Application Filed
Jan 4, 2023
Under Examination
Jun 4, 2024
Approved for Publication
Apr 2, 2024
Published for Opposition
Apr 2, 2024
Registered

Attorney Assistance

Important Deadline Approaching

Statement of Use Due - Extension 2 Granted
Due: December 04, 2025 (150 days remaining)

Missing this deadline could result in abandonment or cancellation of your trademark.

Basic Information

Serial Number
97740705
Deadline
December 4, 2025
Description
Statement of Use or 3rd Extension Due
Filing Date
January 4, 2023
Published for Opposition
April 2, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
May 14, 2025
Application
Pending
Classes
016 035 036 041
+1 more

Rights Holder

Cytokinetics, Incorporated

03
Address
350 Oyster Point Blvd.
South San Francisco, CA 94080

Ownership History

Cytokinetics, Incorporated

Original Applicant
03
South San Francisco, CA

Cytokinetics, Incorporated

Owner at Publication
03
South San Francisco, CA

Legal Representation

Attorney
B. Brett Heavner

USPTO Deadlines

Next Deadline
150 days remaining
Statement of Use Due - Extension 2 Granted
Due Date
December 04, 2025
Extension Available
Until June 04, 2025

Application History

32 events
Date Code Type Description
May 15, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2025 EX2G S SOU EXTENSION 2 GRANTED
May 14, 2025 EXT2 S SOU EXTENSION 2 FILED
May 14, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 9, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 9, 2024 EXT1 S SOU EXTENSION 1 FILED
Oct 9, 2024 EX1G S SOU EXTENSION 1 GRANTED
Oct 9, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 4, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 2, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 2, 2024 PUBO A PUBLISHED FOR OPPOSITION
Mar 13, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 27, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2024 XAEC I EXAMINER'S AMENDMENT ENTERED
Feb 27, 2024 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 27, 2024 GNEA O EXAMINERS AMENDMENT E-MAILED
Feb 27, 2024 CNEA R EXAMINERS AMENDMENT -WRITTEN
Jan 18, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 18, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 20, 2023 GNRT O NON-FINAL ACTION E-MAILED
Nov 20, 2023 CNRT R NON-FINAL ACTION WRITTEN
Oct 24, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 23, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 23, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 12, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 12, 2023 GNRT F NON-FINAL ACTION E-MAILED
Sep 12, 2023 CNRT R NON-FINAL ACTION WRITTEN
Sep 12, 2023 DOCK D ASSIGNED TO EXAMINER
Jan 27, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 016
Printed materials, namely, newsletters in the field of cardiovascular diseases and conditions, speaker communications in the nature of printed articles in the field of cardiovascular diseases and conditions, magazines in the field of cardiovascular diseases and conditions, catalogues in the field of cardiovascular diseases and conditions, posters, informational flyers featuring cardiovascular diseases and conditions, brochures in the field of cardiovascular diseases and conditions, pamphlets in the field of cardiovascular diseases and conditions, graphical prints, and graphical representations in relation to information regarding cardiovascular conditions and patient support programs
Class 035
providing information about medical records coding, billing, and compliance for patients with cardiac conditions for use by healthcare providers, patients, and caregivers
Class 036
Providing financial information about reimbursement for medical expenses for patients with cardiac conditions for use by healthcare providers, patients, and caregivers; providing insurance information about medical benefit verification and prior authorization services for patients with cardiac conditions for use by healthcare providers, patients, and caregivers
Class 041
Education services, namely, providing webinars, seminars, and conferences in the field of cardiac diseases; classes to caregivers and patients regarding treatments and support for cardiovascular conditions
Class 044
Providing information services in the field of cardiac disease for the purpose of patient support, namely, providing medical and healthcare information relating to pharmaceuticals and the treatment of heart diseases and conditions, and medical information about the administration and dosing of pharmaceuticals; Providing a website featuring healthcare information that provides resources in the field of pharmaceuticals for treatment of heart diseases and links to such resources; Providing a website featuring medical information, namely, a website featuring medical information related to patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to treatment of individuals and adherence to pharmaceutical protocols; providing a website featuring medical information featuring information related to medical and diagnostic testing for heart diseases and conditions; medical care consulting services in the fields of patient treatment and treatment protocols; providing medical information and communication from a web site about cardiovascular diseases and conditions; patient healthcare education and services, namely, conducting one-on-one medical counseling in the fields of heart disease and conditions; Providing a website featuring educational information in the field of cardiovascular diseases and conditions about cardiac disease

Classification

International Classes
016 035 036 041 044